September 10th, 2020

On Tuesday, November 17, 2020 from 7:30pm -8:30pm, the Chondrosarcoma CS Foundation, Inc. will host a virtual dialogue using the zoom platform to reach out to sarcoma experts, and oncologists as well as patients diagnosed with Chondrosarcoma and…

September 8th, 2020

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

https://clinicaltrials.gov/ct2/show/NCT03715933?term=DR5+INBRX109&rank=1

Go to

Arm
Intervention/treatment

Experimental: Dose…

September 5th, 2020

Hello my CS brothers and sisters! I wanted to tell you a story about my journey which might help some of you. Here are some details:

–diagnosed in Feb 2017, Grade 1 pelvic CS, spread widely on and around the acetabulum. Offered a hemipelvectomy…

September 3rd, 2020

A CS Warrior on the Facebook Chondrosarcoma Support Group entered a new Phase 2 clinical trial yesterday specifically for unresectable and metastatic conventional CS that combines a histone deacetylase inhibitor Belinostat (FDA approved for a type…

September 2nd, 2020

In September, we honor the gold ribbon in recognition of Childhood Cancer Awareness Month! ✨

Did you know cancer is the second leading cause of death in children under the age of 15? In 2020, approximately 11,000 children ages 1-14 will be…

Testing the Combination of Belinostat and SGI-110 (Guadecitabine) for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma

clinicaltrials.gov

Brief Summary:
This phase II trial studies how well belinostat and SGI-110…

August 31st, 2020

To view the video on YouTube, click here

August 29th, 2020

Schwartz Hunts for Predictive Biomarkers in Soft Tissue Sarcoma

Gary K. Schwartz, MD, highlights research that is being done with regard to genomic signatures in sarcoma, challenges faced with immunotherapy, and where the field is headed.

Gary K….

August 16th, 2020

Targeting the Multidrug Transporter Ptch1 Potentiates Chemotherapy Efficiency

Abstract

One of the crucial challenges in the clinical management of cancer is resistance to chemotherapeutics. Multidrug resistance (MDR) has been intensively studied,…

Results of a Prospective Phase 2 Study of Pazopanib in Patients With Surgically Unresectable or Metastatic Chondrosarcoma
Warren Chow, MD1; Paul Frankel, PhD2; Chris Ruel, PhD2; Dejka M. Araujo, MD3; Mohammed Milhem, MBBS4; Scott Okuno, MD5; Lee…